Menu
Menu
S&PAA embraces a comprehensive approach to learning, geared toward every part of our community—from individuals living with schizophrenia or related disorders, to caregivers, and clinicians. We offer in-depth toolkits, topical webinars, and now, we are introducing structured curricula. Our courses are created and delivered either by our own experts or in collaboration with trusted partners, ensuring that everyone receives relevant, practical, and accessible information to support better outcomes. Our courses often fulfill continuing medical education (CME) requirements.
A Seven-Module Learning Series
Launching in the fall, “A New Era in Clozapine Management” is an educational series sponsored by S&PAA and delivered in collaboration with the American Association of Psychiatric Pharmacists (AAPP), designed to:
The modules will be available at no cost through AAPP and will be accredited.
Modules
Clozapine Through the Patient Lens
From First Dose to Full Effect: Mastering Clozapine Initiation, Adjustments, and Drug Interactions
Navigating Clozapine Monitoring in a REMS-Free Era
From Drooling to Drowsiness: Strategies for Managing Clozapine’s Non-ANC Side Effects
Clozapine Across the Spectrum: Special Populations and Unique Challenges
The Clozapine Rechallenge Dilemma: Who, When, and How?
The Untapped Potential of Clozapine: Lessons from the Past, Path to the Future
If you or someone you love could benefit from life-changing medications, please support our work. Click here to donate any amount to our research and education.
Take our 30-second survey below, and we’ll keep you updated on new developments as the November launch approaches!
Launching in the fall, “A New Era in Clozapine Management” is an educational series sponsored by S&PAA and delivered in collaboration with the American Association of Psychiatric Pharmacists (AAPP), designed to:
The modules will be available at no cost through AAPP and will be pharmacy (ACPE) and medical credit (ACCME) accredited.
Modules
Clozapine Through the Patient Lens
From First Dose to Full Effect: Mastering Clozapine Initiation, Adjustments, and Drug Interactions
Navigating Clozapine Monitoring in a REMS-Free Era
From Drooling to Drowsiness: Strategies for Managing Clozapine’s Non-ANC Side Effects
Clozapine Across the Spectrum: Special Populations and Unique Challenges
The Clozapine Rechallenge Dilemma: Who, When, and How?
The Untapped Potential of Clozapine: Lessons from the Past, Path to the Future
If you or someone you love could benefit from life-changing medications, please support our work. Click here to donate any amount to our research and education.
Take our 30-second survey below, and we’ll keep you updated on new developments as the November launch approaches!
If you or a loved one has thoughts of self-harm, go to a hospital emergency room or dial the National Suicide and Crisis Lifeline at 988.
Keep up with the latest news, events and ways to support us.
Information on this website is not intended to be used for medical diagnosis or treatment.
We are a 501 (c)(3) tax-exempt non-profit organization
(Tax ID 33-1213657)
